Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.
Also called NCT05995600
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT05995600
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05995600. Randomized; single masking; primary purpose prevention. Start 2024-02-20 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE
- Acronym
- APS-STROKE
- Condition
- Antiphospholipid Syndrome
- Condition
- Ischemic Stroke
- Condition
- Transient Ischemic Attack
- Condition
- Cerebrovascular Disease
- Condition
- Cardiovascular Diseases
- Condition
- Major Bleed
- Intervention (Drug)
- Antiplatelet Drug
- Intervention (Drug)
- Warfarin
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Samjin Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct05995600- Content hash
9594edc5685336a111cb05c5d833082abca65e812de0e912c612efa5ff33d20d